CFB
ACH

Cullen/Frost Bankers’s Accendra Health ACH Stock Holding History

Cullen/Frost Bankers’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-71
Closed -$928 – 1433
2024
Q4 		$928 Buy
+71
New +$946 ﹤0.01% 1259

Other funds holding ACH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cullen/Frost Bankers's ACH Position: Q1 2025 in Review

Cullen/Frost Bankers sold out of Accendra Health (ACH) in Q1 2025, closing a stake of 71 shares — an estimated $928 sold.

Cullen/Frost Bankers first reported a position in ACH in Q4 2024 and held it in 1 quarter. The position peaked at $928 in Q4 2024. 242 funds tracked by Wall St. Rank hold ACH as of Q1 2025.

  • Cullen/Frost Bankers reported no remaining Accendra Health position as of Q1 2025 after selling out during the quarter.
  • Cullen/Frost Bankers sold 71 Accendra Health shares in Q1 2025, an estimated $928.
  • Cullen/Frost Bankers first reported a position in Accendra Health in Q4 2024 and held it in 1 quarter.
  • Cullen/Frost Bankers's Accendra Health position peaked at $928 in Q4 2024.
  • 242 funds tracked by Wall St. Rank held Accendra Health as of Q1 2025.

Based on Cullen/Frost Bankers's 13F filing for Q1 2025, filed 2 May 2025.